DECAAF II - Efficacy of DE-MRI-Guided Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation
DECAAF II Logo DECAAF II Logo

Study Status

DECAAF II is a prospective, randomized, multi-center trial of patients with persistent Atrial Fibrillation (AF) and presence of atrial fibrosis. Enrollment is currently underway for this study. Interested patients should contact their local doctor about being involved in this trial.

Study Updates

As of March 15, 2019, we currently have 43 sites enrolling patients. By the end of March 2019, we expect 1 additional site to be enrolling. We currently have 816 patients enrolled in the study.

 

 

 

 

 

 

 

(In accordance with the Americans with Disabilities Act, the information in this site is available in alternate formats upon request.)